Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Aspirin for CRC Risk Reduction May Benefit Unhealthy People Most

2.

The Truth About Apple AirPods

3.

Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care

4.

Living in a more pedestrian-friendly area may reduce the risk of cancer and obesity-related diseases.

5.

Investigating the Relationship Between GERD and Anxiety/Depression.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot